Uzma Haque

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. Arthritis 54%
3. Patient Reported Outcome Measures 36%
4. Knee Osteoarthritis 35%
5. Pain 32%
6. Vitamin D 30%
7. Fragaria 24%
8. Central Nervous System Vasculitis 24%
9. Ipilimumab 23%
10. Nivolumab 22%
11. Carotid Body 22%
12. Central Nervous System Sensitization 22%
13. Intestinal Volvulus 22%
14. Takayasu Arteritis 21%
15. Mucocutaneous Lymph Node Syndrome 20%
16. Dermatomyositis 20%
17. Lupus Nephritis 20%
18. Information Systems 19%
19. Mycophenolic Acid 19%
20. Sjogren's Syndrome 18%
21. Pakistan 18%
22. Vitamin D Deficiency 18%
23. Autoantigens 18%
24. Controlled Clinical Trials 17%
25. Sleep Initiation and Maintenance Disorders 17%
26. Cognitive Behavioral Therapy 16%
27. Biological Products 16%
28. Reproduction 15%
29. Systemic Lupus Erythematosus 15%
30. Tongue 15%
31. Hepacivirus 15%
32. Decision Making 15%
33. Pulmonary Artery 15%
34. India 14%
35. Immunosuppressive Agents 13%
36. Young Adult 13%
37. Colon 13%
38. Pathologic Constriction 13%
39. Creatinine 13%
40. amsonic acid 13%
41. Hypoxia 12%
42. Patient Care 12%
43. Communication 12%
44. Virus Diseases 12%
45. Urine 11%
46. Placebos 11%
47. Calcium 11%
48. Proteins 11%
49. Rheumatic Diseases 10%